Preclinical Efficacy of CD33 Chimeric Antigen Receptor T Cell Immunotherapy in Childhood Acute Myeloid Leukemia

被引：0
|
作者：
Yang, L. [1 ]
Tarun, S. [1 ]
Shen, F. [2 ,3 ]
Qin, H. [1 ]
Chien, C. D. [1 ]
Kohler, M. L. [1 ]
Fry, T. J. [4 ]
Tasian, S. [2 ,3 ]
机构：
[1] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[3] Ctr Childhood Canc Res, Philadelphia, PA USA
[4] Univ Colorado Denver, Pediat Hematol & Immunol, Aurora, CO USA
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-100
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia
    Kraguljac, N
    Marisavljevic, D
    Jankovic, G
    Radosevic, N
    Pantic, M
    Donfrid, M
    Miletic, N
    Boskovic, D
    Colovic, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (01) : 29 - 34
  • [32] Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
    I Pizzitola
    F Anjos-Afonso
    K Rouault-Pierre
    F Lassailly
    S Tettamanti
    O Spinelli
    A Biondi
    E Biagi
    D Bonnet
    Leukemia, 2014, 28 : 1596 - 1605
  • [33] CD33 directed bispecific antibodies in acute myeloid leukemia
    Clark, Mary C.
    Stein, Anthony
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (04)
  • [34] CD33 as a target for selective ablation of acute myeloid leukemia
    Bernstein, ID
    CLINICAL LYMPHOMA, 2002, 2 : S9 - S11
  • [35] The role of CD33 as therapeutic target in acute myeloid leukemia
    Walter, Roland B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (07) : 715 - 718
  • [36] Multi-Antigen Specific Chimeric Antigen Receptor T Cell Therapy for Acute Myeloid Leukemia
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Li, Gongbo
    Boucher, Justin
    Kotani, Hiroshi
    Ghafoor, Tayyebb
    MOLECULAR THERAPY, 2019, 27 (04) : 269 - 269
  • [37] Leukemia targeting via cytotoxic T cells expressing a cd33 specific chimeric receptor
    Dutour, A.
    Lee, D.
    Finney, H.
    Brenner, M.
    Rousseau, R.
    BULLETIN DU CANCER, 2007, 94 (06) : 547 - 547
  • [38] TRANSIENT EXPRESSION OF A CD123-DIRECTED CHIMERIC ANTIGEN RECEPTOR FOR SAFE IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA
    Kitte, R.
    Fricke, S.
    Koehl, U.
    Tretbar, S.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A35 - A35
  • [39] Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia
    Xie Danni
    Wang Bing
    Bai Xue
    Jin Xin
    Lu Wenyi
    Zhang Meng
    Zhang Yi
    Cao Xinping
    Zhao Mingfeng
    中华医学杂志英文版, 2025, 138 (01)
  • [40] Therapeutic Targeting of Mesothelin in Acute Myeloid Leukemia with Chimeric Antigen Receptor T Cell Therapy
    Quy Le
    Castro, Sommer
    Tang, Thao T.
    Loeb, Anisha
    Leonti, Amanda R.
    Pardo, Laura
    Loken, Michael R.
    Correnti, Colin
    Meshinchi, Soheil
    BLOOD, 2020, 136
12345